Arctic Bioscience
ABS | OL
Overview
Corporate Details
- ISIN(s):
- NO0010859580
- LEI:
- 549300Z2HW6I989Q2C78
- Country:
- Norway
- Address:
- Industrivegen 42, 6155 ØRSTA
- Website:
- https://arctic-bioscience.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Arctic Bioscience is a biotechnology company that develops, manufactures, and commercializes pharmaceutical and nutraceutical ingredients derived from marine membrane lipids. Leveraging over 30 years of experience, the company utilizes proprietary technology to extract bioactive compounds, such as high-DHA Omega-3 phospholipids, from sustainably sourced Norwegian herring roe. Its business is structured into two main segments: a nutraceutical division, which markets products under the Romega® brand, and a pharmaceutical division focused on developing novel therapies for autoimmune disorders. The company's approach is founded on extensive scientific research and a commitment to sustainable practices.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Arctic Bioscience.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-28 08:00 |
Investor Presentation
Arctic Bioscience - Stable development with upside potential - Attachment: ABS_…
|
English | 3.7 MB | |
| 2025-08-28 08:00 |
Investor Presentation
Arctic Bioscience - Stabil utvikling med oppsidepotensial - Attachment: ABS_Pre…
|
English | 3.7 MB | |
| 2025-08-28 08:00 |
Interim Report
Arctic Bioscience - Stable development with upside potential - Attachment: ABS_…
|
English | 457.5 KB | |
| 2025-08-28 08:00 |
Interim Report
Arctic Bioscience - Stabil utvikling med oppsidepotensial - Attachment: ABS_Hal…
|
English | 457.5 KB | |
| 2025-08-28 08:00 |
Earnings Release
Arctic Bioscience - Stable development with upside potential
|
English | 7.6 KB | |
| 2025-08-28 08:00 |
Earnings Release
Arctic Bioscience - Stabil utvikling med oppsidepotensial
|
Norwegian | 7.8 KB | |
| 2025-08-21 12:19 |
Report Publication Announcement
Arctic Bioscience - Invitation to presentation of half year 2025 results
|
English | 2.3 KB | |
| 2025-08-21 12:19 |
Report Publication Announcement
Arctic Bioscience - Invitasjon til presentasjon av halvårsresultat for 2025
|
Norwegian | 2.2 KB | |
| 2025-08-18 10:28 |
Regulatory News Service
Arctic Bioscience - Signifikant synsforbedring i klinisk grønn stær-studie
|
Norwegian | 2.6 KB | |
| 2025-08-18 10:28 |
Regulatory News Service
Arctic Bioscience - Achieves significant vision improvement in Clinical Glaucom…
|
English | 2.6 KB | |
| 2025-08-12 13:46 |
Regulatory News Service
Arctic Bioscience lanserer nytt hudpleieprodukt - Romega Skin Refine
|
Norwegian | 3.3 KB | |
| 2025-08-12 13:46 |
Regulatory News Service
Arctic Bioscience launches new skin care product - Romega Skin Refine
|
English | 3.3 KB | |
| 2025-07-01 17:00 |
Investor Presentation
Arctic Bioscience - 12-month data confirm potential for HRO350 in mild-to-moder…
|
English | 3.9 MB | |
| 2025-07-01 17:00 |
Investor Presentation
Arctic Bioscience - 12-måneders data bekrefter potensialet for HRO350 i mild ti…
|
English | 3.9 MB | |
| 2025-07-01 17:00 |
Regulatory News Service
Arctic Bioscience - 12-month data confirm potential for HRO350 in mild-to-moder…
|
English | 3.9 KB |
Automate Your Workflow. Get a real-time feed of all Arctic Bioscience filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Arctic Bioscience via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
